How to Register

Safety and efficacy of long-term esomeprazole 20 mg in Japanese patients with a history of peptic ulcer receiving daily non-steroidal anti-inflammatory drugs

BMC GASTROENTEROLOGY Volume 13 published_at 2013-03-26

アクセス数 : 923 件

ダウンロード数 : 0 件

今月のアクセス数 : 38 件

今月のダウンロード数 : 0 件

この文献の参照には次のURLをご利用ください : https://ir.lib.shimane-u.ac.jp/53783

Title	Safety and efficacy of long-term esomeprazole 20 mg in Japanese patients with a history of peptic ulcer receiving daily non-steroidal anti-inflammatory drugs
Creator	Sugano Kentaro Kinoshita Yoshikazu Miwa Hiroto Takeuchi Tsutomu
Source Title	BMC GASTROENTEROLOGY
Volume	13
Journal Identifire	EISSN 1471-230X
Subjects	Esomeprazole; Non-steroidal anti-inflammatory drugs; Peptic ulcer; Safety ( Other)
Language	eng
Resource Type	journal article
Publisher	BMC
Date of Issued	2013-03-26
Access Rights	metadata only access
Relation	[DOI] 10.1186/1471-230X-13-54 [PMID] 23530709
Remark	Kentaro Sugano: Advisory Board member (AstraZeneca K.K. and Takeda Pharmaceutical Co. Ltd), service honoraria (Takeda Pharmaceutical Co. Ltd) and research grants (Astellas Pharma Inc., AstraZeneca K.K., Eisai Co. Ltd, Otsuka Pharmaceutical Co. Ltd, Chugai Pharmaceutical Co. Ltd, MSD K.K. and Takeda Pharmaceutical Co. Ltd).; Yoshikazu Kinoshita: service honoraria (Astellas Pharma Inc., AstraZeneca K.K., Eisai Co. Ltd and Takeda Pharmaceutical Co. Ltd) and research grants (Astellas Pharma Inc., AstraZeneca K.K. and Eisai Co. Ltd).; Hiroto Miwa: service honoraria (Astellas Pharma Inc., AstraZeneca K.K., Eisai Co. Ltd, Dainippon Sumitomo Pharma Co. Ltd and Takeda Pharmaceutical Co. Ltd) and research grants (Astellas Pharma Inc., AstraZeneca K.K., Dainippon Sumitomo Pharma Co. Ltd and Eisai Co. Ltd and Otsuka Pharmaceutical Co. Ltd).; Tsutomu Takeuchi: service honoraria (Abbott Japan Co. Ltd, Bristol-Myers Squibb, Chugai Pharmaceutical Co. Ltd, Eisai Co. Ltd, Mitsubishi Tanabe Pharma Co. and Pfizer Japan Inc.) and research grants (Abbott Japan Co. Ltd, Astellas Pharma Inc., Bristol-Myers Squibb, Chugai Pharmaceutical Co. Ltd, Daiichi Sankyo Co. Ltd, Eisai Co. Ltd, Janssen Pharmaceutical K.K., Mitsubishi Tanabe Pharma Co., Nippon Shinyaku Co. Ltd, Novo Nordisk Pharma Ltd, Otsuka Pharmaceutical Co. Ltd, Pfizer Japan Inc., Sanofi K.K., Santen Pharmaceutical Co. Ltd, Takeda Pharmaceutical Co. Ltd and Teijin Pharma Ltd).; This study was funded by AstraZeneca K.K. (Japan), the manufacturer of esomeprazole. Medical writing services from Anna Mett and Steve Winter of inScience Communications, Springer Healthcare were funded by AstraZeneca K.K. (Japan).